SUIT-016: Difference between revisions

From Bioblast
No edit summary
Line 1: Line 1:
{{MitoPedia
{{MitoPedia
|abbr=FNS(GM)
|abbr=FNS(GM)
|description=[[File:1OctM,2D,3G,4S,5Rot,6Omy,7U-.jpg|300px]]
|description=[[File:1OctM;2D;3G;4S;5Rot;6Omy;7U-.jpg|300px]]
|info='''A''' [[Gnaiger 2015 Scand J Med Sci Sports]]
|info='''A''' [[Gnaiger 2015 Scand J Med Sci Sports]]
}}
}}
Line 14: Line 14:
__TOC__
__TOC__
== References ==
== References ==
{{#ask:[[Category:Publications]] [[Additional label::SUIT_FNS(GM)01]]
{{#ask:[[Category:Publications]] [[Additional label::SUIT_1OctM;2D;3G;4S;5Rot;6Omy;7U-]]
|?Was published in year=Year
|?Was published in year=Year
|?Has title=Reference
|?Has title=Reference
Line 27: Line 27:




== File:1OctM,2D,3G,4S,5Rot,6Omy,7U,7c-.jpg ==
== SUIT_1OctM;2D;3G;4S;5Rot;6Omy;7U;7c-8Ama ==
[[File:SUIT_FNS(GM)01_U(c).jpg|300px]] FNS(GM)01_1OctM,2D,3G,4S,5Rot,6Omy,7U(c)-
[[File:1OctM;2D;3G;4S;5Rot;6Omy;7U;7c-8Ama.jpg|300px]] 1OctM;2D;3G;4S;5Rot;6Omy;7U;7c-8Ama
::: '''SUIT states:''' 1-2[[OctM]](LP) 3[[GMOct]] 4[[GMSOct]] 5-8[[S]](PLEc) 9[[ROX]]
::: '''SUIT states:''' 1-2[[OctM]](LP) 3[[GMOct]] 4[[GMSOct]] 5-7[[S]](PLEc) 8[[ROX]]


{| class="wikitable" border="1"
{| class="wikitable" border="1"
Line 93: Line 93:
| [[S]]
| [[S]]
| CII
| CII
| If [[cytochrome c control factor]]s = 0.0, the cytochrome ''c'' test conducted at this very late ETS state provides an additional indication of stability of the mt-preparation during the experimental assay. Application of the cytochrome ''c'' test earlier in the protocol ([[SUIT_NS(GM)01]]: 1GM 2D 3c 4S ..) is preferable, if  [[cytochrome c control factor]]s > 0.0 may be observed occasionally or regulary. If such cytochrome ''c'' effects are not exclusion criteria, then OXPHOS states with all substrate combinations can be  compared in the presence of cytochrome ''c''.
| If [[cytochrome c control factor]]s = 0.0, the cytochrome ''c'' test conducted at this very late ETS state provides an additional indication of stability of the mt-preparation during the experimental assay. Application of the cytochrome ''c'' test earlier in the protocol ([[SUIT_NS(GM)01]]: 1GM;2D;2c;3S; ..) is preferable, if  [[cytochrome c control factor]]s > 0.0 may be observed occasionally or regulary. If such cytochrome ''c'' effects are not exclusion criteria, then OXPHOS states with all substrate combinations can be  compared in the presence of cytochrome ''c''.


|-
|-

Revision as of 07:57, 14 March 2017


high-resolution terminology - matching measurements at high-resolution


SUIT-016

Description

1OctM;2D;3G;4S;5Rot;6Omy;7U-.jpg

Abbreviation: FNS(GM)

Reference: A Gnaiger 2015 Scand J Med Sci Sports


MitoPedia concepts: SUIT protocol, SUIT A 






SUIT-category: FNS(GM)
SUIT protocol pattern: diametral

References

SUIT_1OctM;2D;3G;4S;5Rot;6Omy;7U;7c-8Ama

1OctM;2D;3G;4S;5Rot;6Omy;7U;7c-8Ama.jpg 1OctM;2D;3G;4S;5Rot;6Omy;7U;7c-8Ama

SUIT states: 1-2OctM(LP) 3GMOct 4GMSOct 5-7S(PLEc) 8ROX
Step Respiratory state Pathway control Pathway to Q Comment
1OctM OctM(L) F CETF
2D OctM(P) F CETF OXPHOS coupling efficiency in state F.
3G GMOct(P) FN FAO&CI F/N ratio or (N-F)/N flux control factor of OXPHOS capacity.
4S GMSOct(P) FNS FAO&CI&II Additive effect of the NS pathway combination, compared to the sum of N+S pathway fluxes measured separately, in the OXPHOS state and the presence of F.
5Rot S(P) S CII The P/E ratio is not obtained in the FNS state, with preference given to the next steps for OXPHOS coupling efficiency. A succinate concentration of >10 mM may be required for saturating SP capacity.
6Omy S(L) S CII OXPHOS coupling efficiency in state S, comparable to state F.
7U S(E) S CII The complete ETS capacity in state S may not be obtained after oligomycin. If apparent P/E>1.0, this is corrected to 1.0.
7c S(E) S CII If cytochrome c control factors = 0.0, the cytochrome c test conducted at this very late ETS state provides an additional indication of stability of the mt-preparation during the experimental assay. Application of the cytochrome c test earlier in the protocol (SUIT_NS(GM)01: 1GM;2D;2c;3S; ..) is preferable, if cytochrome c control factors > 0.0 may be observed occasionally or regulary. If such cytochrome c effects are not exclusion criteria, then OXPHOS states with all substrate combinations can be compared in the presence of cytochrome c.
8Ama ROX ROX ROX may be lower in substrate states earlier in the SUIT protocol. Therefore, this ROX measurement is frequently taken as a methodological control rather than as the basis of ROX correction of mitochondrial respiration (mt).
Cookies help us deliver our services. By using our services, you agree to our use of cookies.